nach oben

Erschienen in:

03.02.2022 | Diabetes Epidemiology (HC YEH Section Editor)

Mobile Health Technology in the Primary Prevention of Type 2 Diabetes: a Systematic Review

verfasst von: Noël C. Barengo, Paula A. Diaz Valencia, Leticia Manuel Apolina, Norma A. Estrada Cruz, José E. Fernández Garate, Roberto A. Correa González, Cecilia Alicia Cinco Gonzalez, José Alberto Gómez Rodriguez, Nelly Cisneros González, On behalf of the SANENT Study Group

Erschienen in: Current Diabetes Reports | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The objective of this review was to summarize the current scientific evidence of mobile health technology in the primary prevention of type 2 diabetes in patients with prediabetes derived from randomized clinical trials.

Recent Findings

Few randomized clinical trials are available using mobile health technologies in the prevention of type 2 diabetes. There is heterogeneity in regard to the main study outcomes, duration of interventions, and study findings.

Summary

Inconsistent findings have been reported whether mobile health technologies are effective in reducing HbA1C levels or the incidence of type 2 diabetes in patients with prediabetes. However, results are promising that mobile health interventions may decrease body weight. Future study may consistently measure changes in glycemic indicators as well as develop elements that better address behavior changes.

International Diabetes Federation. IDF diabetes atlas. 9th ed. Brussels: International Diabetes Federation; 2019.

WHO. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.

WHO. Global health estimates: deaths by cause, age, sex and country, 2000±2012. Geneva: World Health Organization; 2014.

Pan XR, Li GW, Hu YH, Wand JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.CrossRef

Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, et al. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;4:289–97.CrossRef

Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). JAMA. 1999;281:2005–12.CrossRef

Tuomilehto J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRef

Knowler WC, Barrett-Connor E, Fowler SE. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl JMed. 2002;346:393–403.CrossRef

Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGTmales. Diabetes Res Clin Pract. 2005;67:152–62.CrossRef

10.

Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris WHM, Blaak EE. Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study. Diabetes Med. 2008;25(5):597–605.CrossRef

11.

Ackermann RT, Finch EA, Caffrey HM, Lipscomb ER, Hays LM, Saha C. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic Illn. 2011;7(4):279–90.CrossRef

12.

Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med. 2008;35(4):357–63.CrossRef

13.

Ali K, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31(1):67–75.CrossRef

14.

Costa B, Barrio F, Cabré JJ, Pinol JL, Cos X, Sole C, DE-PLAN-CAT Research Group, et al. Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention. Diabetologia. 2012;55(5):1319–28.CrossRef

15.

Gilis-Januszewska A, Lindström J, Tuomilehto J, Piwonska-Solska B, Topor-Madry R, Szybinski Z, et al. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. BMC Public Health. 2017;17(1):198.CrossRef

16.

Laatikainen T, Dunbar JA, Chapman A, Kilkkinen A, Vartiainen E, Heistaro S, et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health. 2007;7:249.CrossRef

17.

Nilsen V, Bakke PS, Gallefoss F. Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus - results from a randomised, controlled trial. BMC Public Health. 2011;11:893.CrossRef

18.

Penn L, White M, Oldroyd J, Walker M, Alberti KG, Mathers JC. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health. 2009;9:277–83.CrossRef

19.

Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Salteva J, Niskanen L, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care. 2010;33(10):2146–51.CrossRef

20.

Holtz B, Lauckner C. Diabetes management via mobile phones: a systematic review. Telemed J E Health. 2012;18:175–84.CrossRef

21.

Krishna S, Boren SA. Diabetes self-management care via cell phone: a systematic review. J Diabetes Sci Technol. 2008;2:509–17.CrossRef

22.

Russell-Minda E, Jutai J, Speechley M, Bradley K, Chudyk A, Petrella R. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009;3:1460–71.CrossRef

23.

Saffari M, Ghanizadeh G, Koenig HG. Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2014;8(4):275–85.CrossRef

24.

Tao D, Or CK. Effects of self-management health information technology on glycaemic control for patients with diabetes: a meta-analysis of randomized controlled trials. J Telemed Telecare. 2013;19(3):133–43.CrossRef

25.

Fortmann AL, Gallo LC, Garcia MI, Taleb M, Euyoque JA, Clark T, et al. Dulce Digital: An mhealth sms-based intervention improves glycemic control in Hispanics with type 2 diabetes. Diabetes Care. 2017. https://doi.org/10.2337/dc17-0230.CrossRefPubMedPubMedCentral

26.

Napolitano MA, Hayes S, Russo G, Muresu D, Giordano A, Foster GD. Using avatars to model weight loss behaviors: participant attitudes and technology development. J Diabetes Sci Technol. 2013;7(4):1057–65.CrossRef

27.

Williams JP, Schroeder D. Popular glucose tracking apps and use of mHealth by Latinos with diabetes: review. JMIR Mhealth Uhealth. 2015;3(3):e84.CrossRef

28.

Huffman M. Health coaching: a new and exciting technique to enhance patient self-management and improve outcomes. Home Healthc Nurse. 2007;25(4):271–4.CrossRef

29.

Bidargaddi N, Schrade G, Klasnja P, Licinio J, Murphy S. Designing m-Health interventions for precision mental health support. Transl Psychiatry. 2020;10:222. https://doi.org/10.1038/s41398-020-00895-2.CrossRefPubMedPubMedCentral

30.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.CrossRefPubMedPubMedCentral

31.

Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ. 2019;366:14898. https://doi.org/10.1136/bmj.14898.CrossRef

32.

Block G, Azar KM, Romanelli RJ, Block TJ, Hopkins D, Carpenter HA, et al. Diabetes prevention and weight loss with a fully automated behavioral intervention by email, web, and mobile phone: a randomized controlled trial among persons with prediabetes. J Med Internet Res. 2015;17(10):e240. https://doi.org/10.2196/jmir.4897.CrossRefPubMedPubMedCentral

33.

Fischer HH, Fischer IP, Pereira RI, Furniss AL, Rozwadowski JM, Susan L, et al. Text Message support for weight loss in patients with prediabetes: a randomized clinical trial. Diabetes Care. 2016;39(8):1364–70. https://doi.org/10.2337/dc15-2137.CrossRefPubMed

34.

Griauzde D, Kullgren JT, Liestenfeltz B, Ansari T, Johnson EH, Fedewa A, et al. Mobile phone-based program to promote healthy behaviors among adults with prediabetes who declined participation in free diabetes prevention programs: mixed-methods pilot randomized controlled trial. JMIR Mhealth Uhealth. 2019;7(1):e11267. https://doi.org/10.2196/11267.CrossRefPubMedPubMedCentral

35.

Nanditha A, Thomson H, Susairaj P, Srivanichakorn W, Oliver N, Godsland IF, et al. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial. Diabetologia. 2020;63:486–96. https://doi.org/10.1007/s00125-019-05061-y.CrossRefPubMedPubMedCentral

36.

Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2013;1(3):191–8. https://doi.org/10.1016/S2213-8587(13)70067-6.CrossRefPubMed

37.

Toro-Ramos T, Michaelides A, Anton M, Karim Z, Kang-Oh L, Argyrou C, et al. Mobile delivery of the Diabetes Prevention Program in people with prediabetes: randomized controlled trial. JMIR Mhealth Uhealth. 2020;8(7):e17842. https://doi.org/10.2196/17842.CrossRefPubMedPubMedCentral

38.

Wong CK, Fung CS, Siu SC, Lo YY, Wong KW, Fong DY, et al. A short message service (SMS) intervention to prevent diabetes in Chinese professional drivers with pre-diabetes: a pilot single-blinded randomized controlled trial. Diabetes Res Clin Pract. 2013;102(3):158–66. https://doi.org/10.1016/j.diabres.2013.10.002.CrossRefPubMed

39.

The world ban. Mobile cellular subscriptions. https://data.worldbank.org/indicator/IT.CEL.SETS. Accessed November 15, 2021.

40.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012;12:2012.

41.

Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32:56–69.CrossRef

Titel: Mobile Health Technology in the Primary Prevention of Type 2 Diabetes: a Systematic Review
verfasst von: Noël C. Barengo
Paula A. Diaz Valencia
Leticia Manuel Apolina
Norma A. Estrada Cruz
José E. Fernández Garate
Roberto A. Correa González
Cecilia Alicia Cinco Gonzalez
José Alberto Gómez Rodriguez
Nelly Cisneros González
On behalf of the SANENT Study Group
Publikationsdatum: 03.02.2022
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 1/2022
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-021-01445-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Mobile Health Technology in the Primary Prevention of Type 2 Diabetes: a Systematic Review

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin